Arblet

Arblet is a Japanese medtech startup developing wrist-worn wearable devices for continuous, cuff-less blood pressure measurement and physiological monitoring. The company's flagship device is equipped with three types of sensors measuring blood pressure, skin temperature, and heart rhythm, enabling non-invasive tracking of internal body changes over time. Arblet's technology platform extends to cloud-based analysis tools and companion smartphone apps that process sensor data to provide actionable health insights. In October 2024, Arblet's blood pressure calculation software 'Alysis-001' received regulatory approval for long-term blood pressure recording as its intended use. The company has filed patents for blood pressure measurement systems and has been backed by investors including ABBALab, Colopl Next, SG incubate, and Monozukuri Ventures. Arblet targets healthcare providers and consumers seeking ambulatory blood pressure monitoring solutions outside clinical settings.